News

9th Euro-Global Summit on Toxicology and Applied Pharmacology

Euro Toxicology 2017 is comprised of notable keynote speakers and technical sessions on the latest cutting edge research, and designed to stimulate discussion and debate about current issues affecting toxicology globally. The Summit incorporates multiple sessions enhancing the length and breadth of the conference. These include

Food Toxicology
Nano toxicology
Genetic Toxicology and Toxicity Testing
Pharmacology
Human & Health Toxicology
Clinical Toxicology
Pharmacology and Toxicology
Drug Toxicology
Toxicologists Meetings
Forensic Medicine
Toxicology of Metals
Reproductive and Developmental Toxicology
Occupational Toxicology
Toxicologic Pathology
Pharmacology

Toxicology Conference incorporates plenty of new sessions and workshops in store for our participants such as the special Networking sessions, Tox talks and so on.

For more information, please visit the Conference website.

A review of the evidence of use and harm

Please find attached a document from the UK Advisory Council on the Misuse of Drugs detailing 'U-47,700 - a review of the evidence of use and harm'.

Advisory Council on the Misuse of Drugs; 25 pages; December 20, 2016

 

Phytocannabinoids - A review of the generic definition

Please find attached a document from the UK Advisory Council on the Misuse of Drugs detailing  'Phytocannabinoids: a review of the generic definition'.

Advisory Council on the Misuse of Drugs; 28 pages; December 16, 2016

BTS Annual Congress 2017 - 3rd-5th April 2017 Hilton Liverpool

The BTS Annual Congress 2017 programme has a strong speaker line-up this year which hopes to draw in excess of 200 delegates, all key members within the field of toxicology.

We have received extremely positive feedback from many of you who supported last year’s conference and for those of you who are considering attendance for the first time, we are confident that you will find an opportunity suitable for your specific requirements.

This could be the perfect platform for you to meeting key people in the industry, giving you the opportunity to market your business face to face.

You can download the latest provisional programme by clicking HERE.

You can download the Congress Flyer HERE.

For further details please contact the BTS Event Managers or visit the Meeting website:
Executive Business Support Ltd
City Wharf
Davidson Road
Lichfield
Staffordshire
WS14 9DZ
Tel: +44 (0) 1543 442158
E-Mail: events@execbs.com
Web: www.thebts.org

Novel psychoactive substances/NPS; clinical, pharmacological, analytical chemistry, toxicity, legislative, and criminological issues

Dear Colleague,
You may be pleased to know that, as part of the European Commission-funded “Enhancing Police Skills concerning Novel Psychoactive Substances (EPS/NPS)” project Meeting, the Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, within the Department of Pharmacy, Postgraduate Medicine and Pharmacology has organised a conference being held at the Fielder Centre, Hatfield, UK on 16 November 2016.

The one-day conference has the theme: “Novel psychoactive substances/NPS; clinical, pharmacological, analytical chemistry, toxicity, legislative, and criminological issues”.

There will be a number of speakers from partner organisations in the EPS/NPS project as well as European experts in relevant fields.

The current programme is as follows:

SESSION I: Background, epidemiology and new research directions in the NPS

  • Chairs: Owen Bowden-Jones; Mire Zloh; Ornella Corazza
  • Overview on NPS - Fabrizio Schifano (UK)
  • NPS issues; epidemiological data - John Corkery (UK)
  • The role of the deep web/darknet in the NPS spread and market chain (1) - Laura Orsolini (UK)
  • The NPS drug markets in the deep web marketplace (2) - Mara Mignone (Italy)
  • The NPS consumption patterns; results from the virtual ethnography approach - Katalin Felvinczi (Hungary)
  • NPS and legislative changes in Europe; challenges and opportunities - Pasquale Policastro (Poland)

SESSION II: Preclinical research on NPS

  • Chairs: Norbert Scherbaum; Marta Torrens; Magi Farré
  • NPS; Pharmacodynamics issues - Gaetano Di Chiara (Italy)
  • Understanding the differential effects of Spice drugs on mesolimbic dopamine function - Maria Antonietta De Luca (Italy)
  • NPS; analytical and chemical issues by using RAMAN spectroscopy - Jacqueline Stair (UK)
  • Chemical evaluation of internet products containing NPS to investigate supply/distribution chains - Jesus Calvo-Castro/Valentina Guarino (UK)
  • Q&A – discussion

Poster Session over lunch

SECTION III: Clinical research on NPS

  • Chairs: Gaetano Di Chiara; Jacque Stair
  • The NEPTUNE Project - Owen Bowden-Jones (UK)
  • Use of NPS and induced psychiatric symptoms in Ibiza: outcomes from the EIVISSA Project - Giovanni Martinotti (Italy)
  • Synthetic cannabinoids and synthetic-cannabinoid-Induced psychotic disorders - Duccio Papanti (Italy)
  • Dual disorders and NPS - Marta Torrens (Spain)
  • Abuse liability and human pharmacology of mephedrone/synthetic cathinones - Magi Farré (Spain)
  • Pregabalin and gabapentin misuse - Norbert Scherbaum (Germany)

We are inviting a limited number of guests from the law enforcement, forensic, and medical fields both within the UK and Europe.

We would be more than happy to see members of the LTG or some of your colleagues at the event.

We hope to publish the conference abstracts in a special issue of a peer-reviewed journal. In this way not only can we publicise the project but also demonstrate that UH is a leading institution in this field.

We seek now to inform the eclipse to give a better coverage to this event.

Further details about the conference can be obtained from myself, John Corkery (j.corkery@herts.ac.uk) or Valentina Guarino (v.guarino@herts.ac.uk).

Kind regards,
Prof Fabrizio Schifano, Conference Chair
Professor Fabrizio Schifano, MD, FRCPsych
Chair in Clinical Pharmacology and Therapeutics Consultant Psychiatrist
University of Hertfordshire
Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit
School of Life and Medical Sciences
College Lane Campus
Hatfield, Herts
AL10 9AB (UK)
telephone: +44 (0)1707-286107
fax: +44 (0)1707-284506
mobile: +44 (0)753 4915035
email: F.Schifano@herts.ac.uk

The Role of Local Authorities in Tackling Alcohol Misuse

A conference addressing the Impact Alcohol has on Health and Crime in the UK. The number of alcohol related crimes recorded across England was close to 704,000. Moreover, alcohol was a contributing factor to over a million incidences of assaults as well as being associated with a further 125,000 incidences of domestic abuse.


The Role of Local Authorities in Tackling Alcohol Misuse

Addressing the Impact Alcohol has on Health and Crime in the UK

Central London
Wednesday 9th November 2016



In 2016, the Government commissioned a guidance report on alcohol abuse in England. The report stated that during that year, alcohol misuse cost the NHS £3.5 billion. Equally, alcohol related crime cost the tax payer £11.billion for this year as well, significantly increasing the pressure on the criminal justice system.

The impact that alcohol abuse has on public health is considerable. Nearly seven million adults are currently drinking at levels that pose great risks to their health. A further one and a half million adults show genuine signs of alcohol dependence, and annually one million hospital admissions are alcohol related. These figures suggest tackling alcohol misuse requires urgent action in order to alleviate pressure on our National Health Service.

It is also clear that alcohol related crime presents a major challenge to our society, putting increased strain on our police and the criminal justice system. The number of alcohol related crimes recorded across England was close to 704,000. Moreover, alcohol was a contributing factor to over a million incidences of assaults as well as being associated with a further 125,000 incidences of domestic abuse.

With alcohol misuse increasing again following a dip during the recession, this timely symposium will provide delegates an excellent platform to examine the main issues and develop strategies to tackle this problem. It will assess how local authorities can enact stronger licensing laws and look directly at current alcohol education programmes and their effectiveness. From a national perspective speakers will highlight what the Government could do to help local authorities in tackling the problem.

I am pleased to advise you that we offer a 20% early registration discount off the standard delegate rates for all bookings received by the 21st October 2016. For further details about the symposium, please refer to the enclosed event brochure. Do feel free to circulate this information to relevant colleagues within your organisation.

In the meantime, to ensure your organisation is represented, please book online or complete and return the attached registration form at your earliest convenience in order to secure your delegate place(s).


Kind regards,

Conference Team
Public Policy Exchange
Tel: 020 3137 8630
Fax: 020 3137 1459

River Thames boat trip following LTG June meeting

Following our last meeting in June, 50 LTG members, colleagues, sponsors and guests took to the river Thames on our own private hire river boat for our evening social event.  We enjoyed good food, lots of drinks and took in the sights of London on a lovely still summer evening. Whilst others had a good chat with colleagues and made some new friends, some of our younger scientists enjoyed a dance or two on the way back to our mooring!

Thank you to all who came and took part in this evening event, and a special thank you to our two supporting sponsors, Thermo Fisher and Sciex.

Psychoactive Substances Act 2016 - Forensic Strategy: "a useful document for our members'"

The Psychoactive Substances Act 2016 (the PS Act) differs from the established approach to drug control under the Misuse of Drugs Act 1971 (MDA). The PS Act covers substances by virtue of their psychoactive properties, rather than the identity of the drug or its chemical structure. Consequently, there is a requirement for a new forensic capability.

This strategy sets out guidance for Forensic Service Providers (FSPs), law enforcement agencies, prosecuting agencies and expert witnesses to support the operation of the PS Act. It provides guidance on the scientific principles for the new testing regime and the process and evidential considerations to support criminal and civil sanctions under the PS Act. The strategy has been developed by the Home Office with input from the Advisory Council on the Misuse of Drugs (ACMD).

This strategy does not relate to those drugs controlled under the MDA which remains the primary legislation for drug control in the UK.  For controlled drugs, the normal forensic and evidential processes and requirements apply.

Download here the full document in pdf.

1 2 3 4 5 6 >